- Home
- RLGT vs AMLX Comparison
RLGT vs AMLX Comparison
Compare RLGT & AMLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RLGT
- AMLX
- Stock Information
- Founded
- RLGT 2001
- AMLX 2014
- Country
- RLGT United States
- AMLX United States
- Employees
- RLGT N/A
- AMLX N/A
- Industry
- RLGT Oil Refining/Marketing
- AMLX Biotechnology: Pharmaceutical Preparations
- Sector
- RLGT Consumer Discretionary
- AMLX Health Care
- Exchange
- RLGT Nasdaq
- AMLX Nasdaq
- Market Cap
- RLGT 295.7M
- AMLX 330.5M
- IPO Year
- RLGT N/A
- AMLX 2022
- Fundamental
- Price
- RLGT $5.74
- AMLX $3.51
- Analyst Decision
- RLGT
- AMLX Buy
- Analyst Count
- RLGT 0
- AMLX 4
- Target Price
- RLGT N/A
- AMLX $7.50
- AVG Volume (30 Days)
- RLGT 175.4K
- AMLX 772.2K
- Earning Date
- RLGT 05-08-2025
- AMLX 05-08-2025
- Dividend Yield
- RLGT N/A
- AMLX N/A
- EPS Growth
- RLGT 32.26
- AMLX N/A
- EPS
- RLGT 0.29
- AMLX N/A
- Revenue
- RLGT $858,699,000.00
- AMLX $87,371,000.00
- Revenue This Year
- RLGT $12.86
- AMLX N/A
- Revenue Next Year
- RLGT $5.75
- AMLX N/A
- P/E Ratio
- RLGT $19.64
- AMLX N/A
- Revenue Growth
- RLGT N/A
- AMLX N/A
- 52 Week Low
- RLGT $4.83
- AMLX $1.58
- 52 Week High
- RLGT $7.94
- AMLX $7.27
- Technical
- Relative Strength Index (RSI)
- RLGT 30.72
- AMLX 47.52
- Support Level
- RLGT $6.04
- AMLX $3.23
- Resistance Level
- RLGT $6.30
- AMLX $3.83
- Average True Range (ATR)
- RLGT 0.17
- AMLX 0.26
- MACD
- RLGT -0.01
- AMLX -0.02
- Stochastic Oscillator
- RLGT 7.95
- AMLX 36.36
About RLGT Radiant Logistics Inc.
Radiant Logistics Inc operates as a third-party logistics company, providing multi-modal transportation and logistics services to customers based in the United States and Canada. The company offers domestic and international air and ocean freight forwarding services and freight brokerage services including truckload services, less-than-truckload (LTL) services, and intermodal services. It has two geographic operating segments: the United States and Canada. Maximum revenue is generated in the United States.
About AMLX Amylyx Pharmaceuticals Inc.
Amylyx Pharmaceuticals Inc is a clinical-stage pharmaceutical company working on developing a novel therapeutic for amyotrophic lateral sclerosis and other neurodegenerative diseases. It has one operating segment which is the business of researching and developing therapeutics for neurodegenerative disorder and endocrine conditions.